BridgeMD
New treatment option for Insomnia
Official title Implementation of CBT-I in Cancer Clinics
ClinicalTrials.gov ID: NCT04817163
What this study is testing
- What it's testing
- Insomnia affects 30-60% of cancer patients, thus making it one of the most common disturbances in this population. When untreated, which is the rule rather than the exception, insomnia often becomes chronic.
- Time commitment: about 20 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- have received a diagnosis of non-metastatic cancer (any type)
- to be aged 18 years and older
- to be readily able to read and understand French or English
- having the minimum cognitive abilities to read, understand and memorize information
- having access to Internet
You likely can't join if
- having a psychological comorbidity needing clinical attention (e.g., major depressive disorder)
- having severe cognitive impairments (e.g., diagnosis of Parkinson's disease, dementia)
- having insomnia due to a temporary condition (e.g., acute pain, short-term medication side effects, environmental factors)
The study team makes the final eligibility decision.
Where it's taking place
- Québec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 20 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Québec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.